Penserra Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Penserra Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,224	Closed	-$428K	–	936
2020 Q2	$428K	Sell	8,224 -1,451	-15%	-$62.2K	0.02%	379
2020 Q1	$418K	Sell	9,675 -44,661	-82%	-$1.49M	0.03%	355
2019 Q4	$1.82M	Buy	+54,336	New	+$1.73M	0.12%	190
2018 Q4	–	Sell	-70,484	Closed	-$2.36M	–	618
2018 Q3	$2.36M	Buy	+70,484	New	+$2.23M	0.14%	103

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

MCM

Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CFA

Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

CAN

Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return

Penserra Capital Management's ARKG Position: Q3 2020 in Review

Penserra Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2020, closing a stake of 8,224 shares — an estimated $428K sold.

Penserra Capital Management first reported a position in ARKG in Q3 2018 and held it in 4 quarters. The position peaked at $2.36M in Q3 2018. 243 funds tracked by Wall St. Rank hold ARKG as of Q3 2020.

Penserra Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2020 after selling out during the quarter.
Penserra Capital Management sold 8,224 ARK Genomic Revolution ETF shares in Q3 2020, an estimated $428K.
Penserra Capital Management first reported a position in ARK Genomic Revolution ETF in Q3 2018 and held it in 4 quarters.
Penserra Capital Management's ARK Genomic Revolution ETF position peaked at $2.36M in Q3 2018.
243 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2020.

Based on Penserra Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.